Geron CORP Schedule 13G passive stakes

RA Capital Management and its affiliates now beneficially own 9.9% of Geron Corporation's common stock, primarily through RA Capital Healthcare Fund, L.P., following an amendment to their Schedule 13G filing.

State Street Corporation has reported beneficial ownership of 5.6% of Geron Corporation's common stock as of June 30, 2026.

Deep Track Capital, LP, along with its affiliates, has reported beneficial ownership of 4.95% of Geron Corp's common stock as of March 31, 2026.

Soleus Capital has filed a Schedule 13G reporting a 6.5% beneficial ownership stake in Geron Corporation.

The Vanguard Group has filed an amended Schedule 13G, reporting zero beneficial ownership in Geron Corp common stock following an internal realignment.

Soleus Capital Master Fund and its affiliates have reported a 5.2% beneficial ownership stake in Geron Corporation, totaling 33,008,659 shares.

Deep Track Capital, LP and affiliated entities have disclosed a 5.09% beneficial ownership stake in Geron Corp, totaling 32,511,271 shares.

Deep Track Capital and affiliates disclosed a 6.75% beneficial ownership stake in Geron Corp, holding 43 million shares as of June 30, 2025.

RA Capital Management, along with its affiliated entities and controlling persons, has disclosed a beneficial ownership of 9.9% in Geron Corporation's common stock as of March 31, 2025.

Deep Track Capital, LP, along with Deep Track Biotechnology Master Fund, Ltd. and David Kroin, has disclosed a passive beneficial ownership of 5.5% in Geron Corp's common stock.

RTW Investments, LP and its Managing Partner, Dr. Roderick Wong, have reported a 0% beneficial ownership in Geron Corporation as of December 31, 2024, indicating a full divestment of their previous holdings.